UMIN-CTR Clinical Trial

Recruitment status No longer recruiting
Unique ID issued by UMIN UMIN000022343
Receipt No. R000025755
Official scientific title of the study Optimization of intravenous vancomycin treatment schedule for pediatric population with Monte Carlo Simulation
Date of disclosure of the study information 2016/05/19
Last modified on 2018/12/27 (Ver. 2)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Optimization of intravenous vancomycin treatment schedule for pediatric population with Monte Carlo Simulation
Title of the study (Brief title) Optimization of intravenous vancomycin treatment schedule for pediatric population with Monte Carlo Simulation
Region
Japan

Condition
Condition Patients under 18 years old who were administered intravenous vancomycin in Department of Pediatrics or Department of Pediatric Cardiology in our institute between April 1st 2011 and March 31st 2016.
Classification by specialty
Pediatrics
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To determine the optimal treatment schedule of vancomycin for pediatric patients with Monte Carlo Simulation.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes The proportion of the patients who achieved more than 400 of AUC/MIC in the present treatment strategy in our institute.
Key secondary outcomes To compare the duration required for body temperature to be normalized between the populations with AUC/MIC above 400 and below 400.
With Monte Carlo simulation, we will optimize the treatment strategy of vancomycin so that more than 90% of the patients achieve AUC/MIC more than 400.

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit

Not applicable
Age-upper limit
18 years-old >
Gender Male and Female
Key inclusion criteria Patients who were administered intravenous vancomycin in Department of Pediatrics or Department of Pediatric Cardiology between April 1st 2011 and March 31st 2016.

Age under 18 years when vancomycin was initiated.

Written informed consent is obtained.
Key exclusion criteria Patients with renal dysfunction.

Data unavailability exists.

Lack of informed consent.
Target sample size 100

Research contact person
Name of lead principal investigator Reo Tanoshima
Organization Yokohama City University
Division name Department of Pediatrics
Address Fukuura 3-9, Kanazawa-ku, Yokohama, Kanagawa, Japan
TEL (+81)45-787-2800
Email tanotch@yokohama-cu.ac.jp

Public contact
Name of contact person Reo Tanoshima
Organization Yokohama City University
Division name Department of Pediatrics
Address Fukuura 3-9, Kanazawa-ku, Yokohama, Kanagawa, Japan
TEL (+81)45-787-2800
Homepage URL
Email tanotch@yokohama-cu.ac.jp

Sponsor
Institute Department of Pediatrics,
Yokohama City University
Institute
Department

Funding Source
Organization Department of Pediatrics,
Yokohama City University
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2016 Year 05 Month 19 Day

Progress
Recruitment status No longer recruiting
Date of protocol fixation
2016 Year 05 Month 12 Day
Anticipated trial start date
2016 Year 05 Month 12 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information Pediatric patients who were administered vancomycin between April 1st 2011 to March 31st 2016 in Department of Pediatrics or Department of Pediatric Cardiology.

Management information
Registered date
2016 Year 05 Month 18 Day
Last modified on
2018 Year 12 Month 27 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000025755